1. 253 Anti-TIGIT antibodies require enhanced FcγR co-engagement for optimal T and NK cell-dependent anti-tumor immunity. (10th December 2020) Authors: Ward, Rebecca; Paltrinieri, Elena; Marques, Marilyn; Iyer, Priyadarshini; Dietrich, Sylvia; Waight, Jeremy; Bushell, Mark; Wilson, Nicholas; Buell, Jennifer; Savitsky, David; Chand, Dhan Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 377 AGEN2373 is a CD137 agonist antibody designed to leverage optimal CD137 and FcγR co-targeting to promote antitumor immunologic effects. (10th December 2020) Authors: Galand, Claire; Venkatraman, Vignesh; Marques, Marilyn; Strauss, James; Carvajal, Richard; Lim, Min; Morin, Benjamin; Ignatovich, Olga; Findeis, Mark; Underwood, Dennis; Dijk, Marc Van; Shapiro, Irina; Ohanjanian, Lernik; Wijatyk, Anna; Wilson, Nicholas; Buell, Jennifer; Chand, Dhan; Savitsky, Da... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 377 AGEN2373 is a CD137 agonist antibody designed to leverage optimal CD137 and FcγR co-targeting to promote antitumor immunologic effects. (9th November 2020) Authors: Galand, Claire; Venkatraman, Vignesh; Marques, Marilyn; Strauss, James; Carvajal, Richard; Lim, Min; Morin, Benjamin; Ignatovich, Olga; Findeis, Mark; Underwood, Dennis; Dijk, Marc Van; Shapiro, Irina; Ohanjanian, Lernik; Wijatyk, Anna; Wilson, Nicholas; Buell, Jennifer; Chand, Dhan; Savitsky, Da... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗